MedTrace Logo

Cough Monitoring in COPD

NCT07098793 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2025-08-01

No results posted yet for this study

Summary

This is an observational study designed to learn about symptoms of cough and how changes in cough may be associated with the beginning of a COPD exacerbation (acute worsening of symptoms.

The Investigators are looking to recruit patients diagnosed with COPD who have had two or more exacerbations of their disease within the last year requiring treatment with antibiotics or corticosteroids.

The main question aimed to be answered is whether the cough monitor can detect changes in a patient's clinical condition.

Patients will be screened for participation in the study and a medical history will be taken alongside details of current medications, height, weight, vital signs as well and smoking status.

The patients will be asked to complete 3 questionnaires and the cough monitor will be installed in the room within their home where they sleep.

Patients will be asked to complete a daily diary for 90 to a maximum of 180 days and leave the monitor recording cough throughout this time.

Conditions

Interventions

DEVICE

Cough monitoring

continuous recording of cough in patients sleeping area for 90-180 days

Sponsors & Collaborators

  • Philips Electronics Nederland B.V. acting through Philips CTO organization

    collaborator INDUSTRY

  • Hull University Teaching Hospitals NHS Trust

    lead OTHER_GOV

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-18
Primary Completion
2024-06-19
Completion
2024-10-10

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07098793 on ClinicalTrials.gov